These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17187491)

  • 21. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.
    Allen MH; Hirschfeld RM; Wozniak PJ; Baker JD; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):272-5. PubMed ID: 16449481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
    Adler CM; Fleck DE; Brecher M; Strakowski SM
    J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate.
    Senturk V; Goker C; Bilgic A; Olmez S; Tugcu H; Oncu B; Atbasoglu EC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():136-44. PubMed ID: 17543032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study.
    Montoya A; Pérez Sánchez Toledo J; Gilaberte I; González-Pinto A; Haro JM; Vieta E; Tohen M
    Actas Esp Psiquiatr; 2007; 35(5):315-22. PubMed ID: 17885823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticonvulsants in bipolar disorders: current research and practice and future directions.
    Bowden CL
    Bipolar Disord; 2009 Jun; 11 Suppl 2():20-33. PubMed ID: 19538683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics, drug interactions, and tolerability of valproate.
    DeVane CL
    Psychopharmacol Bull; 2003; 37 Suppl 2():25-42. PubMed ID: 14624231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproate: do formulations matter?
    Citrome L
    J Clin Pharm Ther; 2008 Aug; 33(4):457; author reply 458. PubMed ID: 18613865
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful reintroduction of valproic acid after the occurrence of pancytopenia.
    Stewart JT
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):351-3. PubMed ID: 21962938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproate.
    Bowden CL
    Bipolar Disord; 2003 Jun; 5(3):189-202. PubMed ID: 12780873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunct extended-release valproate semisodium in late life schizophrenia.
    Sajatovic M; Coconcea N; Ignacio RV; Blow FC; Hays RW; Cassidy KA; Meyer WJ
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):142-7. PubMed ID: 17582828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizophrenia and valproate.
    Citrome L
    Psychopharmacol Bull; 2003; 37 Suppl 2():74-88. PubMed ID: 15021863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of serum valproate concentration to response in mania.
    Bowden CL; Janicak PG; Orsulak P; Swann AC; Davis JM; Calabrese JR; Goodnick P; Small JG; Rush AJ; Kimmel SE; Risch SC; Morris DD
    Am J Psychiatry; 1996 Jun; 153(6):765-70. PubMed ID: 8633687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid oral loading of extended release divalproex in patients with acute mania.
    Miller BP; Perry W; Moutier CY; Robinson SK; Feifel D
    Gen Hosp Psychiatry; 2005; 27(3):218-21. PubMed ID: 15882770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended-release carbamazepine (Equetro) for bipolar disorder.
    Med Lett Drugs Ther; 2005 Mar; 47(1205):27-8. PubMed ID: 15795684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Valproate induced hypoactive delirium in a bipolar disorder patient with psychotic features].
    Ozen S; Bülbül I; Soyuçok E
    Turk Psikiyatri Derg; 2010; 21(1):79-84. PubMed ID: 20204907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.